Since its formation in 1992, Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. A combination of strong organic growth and a progressive acquisition-led strategy has seen the company assemble an impressive portfolio of over 400 products to date.
Specialising in the development, manufacture and marketing of diagnostic test kits, Trinity Biotech’s continued success is based on the fact that as a company it consistently achieves standards of excellence in the quality of all it does.
The test kits manufactured by Trinity Biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. The company is also a significant provider of raw materials to the life sciences industry.
Quoted on the NASDAQ exchange, and with facilities spanning Europe and America, Trinity Biotech sells its products in more than 75 countries. It reaches this worldwide market by combining the skills of its own sales force with a network of international distributors and strategic partners.
Trinity Biotech has manufacturing facilities in:
Bray, Ireland - Rapids, Infectious Disease
Carlsbad, USA – Infectious Disease – Western Blot, Point-of-care development
Acton, USA – Raw materials for supply to the research and diagnostic industries
Jamestown, USA – Infectious Disease – Enzyme Immunoassay (EIA)
Kansas City, USA –Diabetes Diagnostics based on Boronate Affinity HPLC
自從1992年建立以來,Trinity Biotech 公司繼續積極從事于診斷行業,目標是成為一個*者。強有機的增長和不斷進步的戰略模式見證了公司的榮譽。 迄今為止Trinity Biotech 公司組裝過的組合已經超過了400種。
專業發展于診斷器材的銷售和制造, 三一生物技術的持續成功依賴于公司始終如一的質量標準。
Trinity Biotech公司生產測試套件主要用于
臨床實驗室和臨時診斷市場細分的探測傳染病、性傳播疾病、自身免疫和血紅蛋白疾患、探測、監視和控制糖尿病方面。
公司也是生命科學行業理重要的原材料供應商。
從納斯達克交易所獲悉,三一生物技術產品已經橫跨歐洲和美國熱銷于世界上75個國家。通過自身的技能和網絡銷售能力已經與世界各地的分銷商形成了戰略伙伴關系。
TRINITY 公司是的臨床診斷試劑及臨床免疫類儀器生產供應商,*納斯達克上市的醫藥企業。公司商業總部位于愛爾蘭都柏林,在紐約Jamston, California,,英國warehouse, 德國,加拿大,瑞典均設有生產基地。自1992年成立以來,已在收購十多家醫藥生物公司。其產品范圍包括自身免疫性疾病的診斷,激素類診斷試劑,藥物監測,性傳播疾病和傳染病血清學診斷,及臨床血液部門檢測(Sigma),臨床凝血檢測(Biopool)。
Trinity Biotech的制造設備基地如下:
布雷,愛爾蘭-急流,傳染病
卡爾斯巴德,美國-傳染病,免疫印跡,現階段的發展
阿克頓,美國-原材料供應的研究和診斷行業
詹姆斯敦,美國-傳染病——酶免疫測定(EIA)
堪薩斯城,美國--基于液相色譜Boronate親和力糖尿病診斷
METHOD Dye Reduction, Visual Colour (qualitative)
PRINCIPLE
The rate at which the colour visually disappears in the reaction mixture is proportional to the G-6-PDH content of red cells.
PRODUCTBRANDCODEKIT
G-6-PDH Trizma Buffer SolutionTrinity Biotech400-4-5050 ml
G-6-PDH Dye Reduction Kit (5 assays/vial)Trinity Biotech400K-100-5X20Maximum Assays: 100
G-6-PDH Mineral Oil 1 LiterTrinity Biotech400-5-10001 L
G-6-PDH Dye Reduction Kit (10 assay/vial)Trinity Biotech400K-100XMaximum Assays: 100
G-6-PDH Mineral Oil - 100 mlTrinity Biotech400-5-100100 ml
G-6-PDH 10-Assay Vial (10 vials)Trinity Biotech400-10x1010 vials
G6PDH Substrate Kit 5 Tests/ VialTrinity Biotech400-5x1010 Vials